Treatment of Gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers

摘要

Provided is a method of monitoring the treatment of Gaucher disease with specificpharmacological chaperones using systemic and/or cellular surrogate markers.Also provided is a new biomarker that may be used to monitor the progress of suchtreatment.